US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

ホーム
投資
株式
オーストラリア
ASX
Oneview Healthcare PLC (ONE) 銘柄情報

Oneview Healthcare PLC (ONE)

0.17

0.00

( 0.00% )

更新日時： 09:00:00

Oneview Healthcare PLC (ONE) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.17

( - )

買値

0.16

売値

0.17

出来高

-

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

0.17

始値

-

時刻

最終取引時間

-

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 193,261

発行済株式数

838,984,723

配当利回り

PER

-5.53

1 株当たり利益 (EPS)

-0.02

歳入

12M

純利益

-12.59M

Oneview Healthcare PLC develops and sells software services for the healthcare sector in Ireland, the United States, Australia, the Middle East, and Asia. The company provides patient experience, care team experience, and health system and hospital solutions; and system integrations for HER/EMP/PAS,... Oneview Healthcare PLC develops and sells software services for the healthcare sector in Ireland, the United States, Australia, the Middle East, and Asia. The company provides patient experience, care team experience, and health system and hospital solutions; and system integrations for HER/EMP/PAS, virtual care, interpretations, middleware, clinical communications, dietary, IoT: RTLS and building automation, patient education and portals, entertainment and gaming, calming and distraction, and consumer streaming and social. It also offers secure software development lifecycles, data classification, and third-party penetration testing services. The company was founded in 2008 and is based in Dublin, Ireland. 詳細を表示

セクター

Healthcare

業界

Healthcare Providers & Services

ウェブサイト

www.oneviewhealthcare.com

本社

Dublin, Ireland

設立

2026

Oneview Healthcare PLC is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker ONE. The last closing price for Oneview Healthcare was AUD0.17. Over the last year, Oneview Healthcare shares have traded in a share price range of AUD 0.00 to AUD 0.00.

Oneview Healthcare currently has 838,984,723 shares in issue. The market capitalisation of Oneview Healthcare is AUD142.63 million. Oneview Healthcare has a price to earnings ratio (PE ratio) of -5.53.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

ONE - Frequently Asked Questions (FAQ)

What is the current Oneview Healthcare PLC share price?

The current share price of Oneview Healthcare PLC is AUD 0.17

How many Oneview Healthcare PLC shares are in issue?

Oneview Healthcare PLC has 838,984,723 shares in issue

What is the market cap of Oneview Healthcare PLC?

The market capitalisation of Oneview Healthcare PLC is AUD 142.63M

What is the 1 year trading range for Oneview Healthcare PLC share price?

Oneview Healthcare PLC has traded in the range of AUD 0.00 to AUD 0.00 during the past year

What is the PE ratio of Oneview Healthcare PLC?

The price to earnings ratio of Oneview Healthcare PLC is -5.53

What is the cash to sales ratio of Oneview Healthcare PLC?

The cash to sales ratio of Oneview Healthcare PLC is 7.73

What is the registered address of Oneview Healthcare PLC?

The registered address for Oneview Healthcare PLC is Blackrock, Dublin, Co. Dublin, A94 R7W3

What is the Oneview Healthcare PLC website address?

The website address for Oneview Healthcare PLC is www.oneviewhealthcare.com

Which industry sector does Oneview Healthcare PLC operate in?

Oneview Healthcare PLC operates in the Healthcare Providers & Services sector

nowwhat2

nowwhat2 5分前

Boy, that was really sumpthin' huh ?

Biotrader23

Biotrader23 7分前

spoke today with Alex Arzeno of SCR Partners whom Terrie K (or jing ma) hired for IR.. dude seems to have decent background in real estate biz namely REITs but complete nube in biotech/healthcare.. they never served any publicly traded biotechs so cant really blame them, they wouldnt say no to new c

norisknorewards

norisknorewards 7分前

Maybe nwbo displayed (the misunderstood) pfs endpoint first (before the OS result), on purpose, on that Mulholland slide deck on that fateful day.

I think, in my opinion, dilution is the last thing LP is worried about, because maybe, maybe, she actually did foresee how this would play

lakers17

lakers17 8分前

Many reasons. Human nature, lack of money, jealousy of others having more success than they do and many more reasons. Like I always say, trust the process. It's clear what is being developed in the US. Clarity is important but so is getting crypto in the Federal Reserve. That's just the US. 21

Investor082

Investor082 9分前

There were a lot of dreamers like you pre TLD and JAMA expecting $20+ share price in 2022 and had already made plans on spending it. Make sure LP and her financiers don’t take you for a ride while you’re en-route to the beach. That scream could end up being in anguish, LOL! ;)

Gravedigger1

Gravedigger1 9分前

Morality?I’m judging your use of time - entirely your choice and on full display - while you have a claim to incredible experience, insight, knowledge, foresight(!!!), and pity the rest of the investment world.
Newsflash:Some people make money and don’t need to “guard” a stock daily.
T

axelvento

axelvento 10分前

New cancer vaccine delivers stunning result against one of the deadliest skin cancers

KEYNOTE-942
After about a five-year follow-up, the combo drug was found to reduce the risk of melanoma recurrence or death by 49% compared to pembrolizumab alone.

According to

TexasMarvL

TexasMarvL 11分前

CEO Kimberly Ann.
She definitely has a lot of confidence. I want to hang on just to she if she can deliver.

https://youtu.be/htDcyIyYums?si=7RxZ3lRhGaQu-PQE

chen1992

chen1992 12分前

The fact that we aren’t talking about FID anymore and now all eyes are on the 8-K is surreal. It feel dream like after so many letdowns

douginil

douginil 15分前

Hmmmm

I wonder if our process into metals and oxides gets us into 5 nine purity.

Investor2014

Investor2014 15分前

Ah, OhSay’s older and wiser brother finally arrives, very late in the Anavex saga and, unlike his younger brother, having actually made money from his $AVXL insights. That apparently now qualifies you to lecture others on morality and judge message-board posters with unwavering conviction.

Investors3

Investors3 16分前

I agree with you. If BTC was a good investment at a higher price, then why not buy more, when it is down? I actually find my crypto investments much more exciting than my stock investments. And being able to buy when i want (24 x7) is also a nice benefit. Yes, i don't understand why some people cele

georgejjl

georgejjl 17分前

New Treatment for Alzheimer’s and Parkinson’s Discovered in JapanResearchers use a vitamin K and vitamin A hybrid to transform stem cells into functional neurons, offering a potential path to restoring lost brain function.

https://www.inc.com/lucia-auerbach/future-of-brain-health-how-

ZenChimera371

ZenChimera371 17分前

So, a couple things here.

1. There seems to be inconsistency in the filing regarding communication about convertible debt reduction. They claimed 1 million reduction but I am not seeing that reduction noted in the actual filings for that time period.

2. How are they avo

Biotrader23

Biotrader23 17分前

call it BS since they signed off on the CSR

SemperFITrader

SemperFITrader 19分前

FMc, Both CTBVEAG and CHM are under Licensing, how many times do I have to say that, nothing else really has to be stated past that. CTA data is meaningless since it relates to Clinical Trial Acceptance. Marketing Authorisation under Licenses is the key to both meetings period.
I asked you

Split T

Split T 20分前

Wow, LIBOR and Ezell litigation ends and some of you think that the price is dropping because sellers are pulling listings..lol. you might ought to rethink why the shorts are buying hand over fist.

Biotrader23

Biotrader23 23分前

Been holding sig AVXL position for the last 5 years, regulatory setbacks are common in biotech world, some of my best winners had to overcome those..

Since we have no cash/runway issues my biggest worry at the moment is the direction: Jing Ma (aka SPAC queen) firmly in charge, just lo

Nightdaytrader

Nightdaytrader 23分前

There are so many mistakes and falsehoods in this AI Project West post. Too many to comment on..

There is also this AI statement which is totally wrong. AI stated: "Releasing JPM and others from potential claims (including willful misconduct carve-outs or negotiations around them)

GreenShoots

GreenShoots 29分前

Everybody sees what you refuse to. Don’t be mad cuz you down and out. Don’t hate people that have been here for so long and NOW see the TRUTH. You wanna go down with the ship, do it. Just don’t hate people that see what is happening

skitahoe

skitahoe 30分前

I believe it the Will Rodger's simple stock advice, Buy Good Stock.
The fact that it's been down much of the time I've been in it leads to his principle that if it's up, good, if it's down, better, buy more.

If the stock had moved up from the time I first bought it, I doubt i

cadillacdave

cadillacdave 34分前

There is a high short interest here, so there will be a lot of volatility. Sell the spikes and buy the lows.

It's been a traders stock for quite some time. When big news hits and takes out the shorts, things may change here.

lakers17

lakers17 36分前

BTC back over $64,400. Trust the process, ignore the noise. It's pretty simple. Either you believe in crypto and are holding or averaging down and or you don't believe in crypto and never buy anything. Every time BTC drops the noise emerges out of the closet. I have most on ignore now. I will

JusDePomme

JusDePomme 37分前

Look for devs type move here ahead

JusDePomme

JusDePomme 37分前

Can't believe some traders attack bid after hour while PPS look stunning all day with new high

Oneview Healthcare

Nektar Therapeutics

Petrel Resources

TMT Investments

Mutares SE and Co KGaA

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。